Skip to main content
. 2001 Aug;39(8):2760–2767. doi: 10.1128/JCM.39.8.2760-2767.2001

TABLE 1.

Distribution of agr class, core gene RFLPs, accessory gene carriage and RFLPs, 16S rRNA ribotypes and phage group among reference strains and MSSA isolatesa

Cluster Strain Sourceb agr classc Core genes
Accessory genes
16S rRNA ribotypee Phage groupf
rnaIII sarA ssp spa icaA fnbA efb hlb hlg cna cap5 cap8 lukE splB tst sea seb sec sed seg seh sei
8325-4 Reference I 2.3 + 12 21 9 9.4 8 2.8 4 + 6 4 2.1 +  6 4 6 17 I I
SA502A Reference II 2.3 + 7.5 21 7 9.4 8 3.8 4 + 7 3.5 + 7.7 2.1 + 6 4 3.8 9.4 4 8.2 8.2 I I
RN8463 Reference III 2.3 + 14 9.5 7 + 20 7.9 10 3.8 5.5 6 + 7.7 2.1 + 6 17 0.8 + 14 16 7.7 + 8.5 5.8 5.8 II I
RN4850 Reference IV 1 + 5.5 21 7 10 10 4.2 3.5 19 2.1 + 6 9.4 0.8 + 14 4.5 6 2.5 4 V II
agr class III PM2 Sputum III 2.3 + 14 9.5 7 + 20 7.9 10 3.8 5.5 4.6 2.1 + 6 17 0.8 + 14  3   4 II I
PM47 Blood culture III 2.3 + 14 9.5 7 + 20 7.9 10 3.8 5.5 9 + 19 2.1 + 6 0.8 + 14 16   5.8 14 5.8 II NT
PM116 Lung post mortem III 2.3 + 14 9.5 7 + 20 7.9 10 3.8 5.5 6 + 7.7 2.1 + 6 17 0.8 + 14 16   7.7 + 8.5 5.8 5.8 II I
PM122 Nose III 2.3 + 14 9.5 7 + 20 7.9 10 3.8 5.5 9 2.1 + 6 17 0.8 + 14 16   5.8 5.8 II I
PM37 Blood culture III 2.3 + 12 9.5 7 + 20 7.9 10 3.8 5.5 9 + 19 2.1 + 6 0.8 + 14 16   5.8 14 5.8 II I
PM58 Sputum III 2.3 + 12 9.5 7 + 20 7.9 10 3.8 5.5 4.6 2.1 + 6 17 0.8 + 14  6   4 5.8 5.8 II I
SGH-1 PM13 Blood culture I 2.3 + 7.5 17 5 10 15 3.8 3.5 7.7 1.2 + 6 9.4 0.8 + 14 9.4 9.4 VII I
PM35 Blood culture I 2.3 + 7.5 17 5 10 15 3.8 3.5 6 1.2 + 6 9.4 0.8 + 14 4 9.4 9.4 VII I
PM52 Blood culture I 2.3 + 7.5 17 5 10 15 3.8 3.5 6 1.2 + 6 9.4 0.8 + 14 5.5 9.4 9.4 VII I
PM54 Blood culture I 2.3 + 7.5 17 5 10 15 3.8 3.5 6 1.2 + 6 9.4 0.8 + 14 5.5 9.4 9.4 VII I
PM83 Blood culture I 2.3 + 7.5 17 5 10 15 3.8 3.5 6 1.2 + 6 9.4 0.8 + 14 9.4 9.4 VII I
PM127 Sputum I 2.3 + 7.5 17 5 10 15 3.8 3.5 6 1.2 + 6 9.4 0.8 + 14 4 9.4 9.4 VII I
PM94 Nose I 2.3 + 7.5 17 5 + 7 10 15 3.8 3.5 6 1.2 + 6 9.4 0.8 + 14 3.6 9.4 4 14 14 VII NT
SGH-2 PM20 Blood culture I 2.3 + 12 21 9 9.4 8 2.8 4 + 6 4 + 7.3 + 7.7 2.1 + 6 4 6 17 2.5 + 6.7 4 I I
PM23 Blood culture I 2.3 + 12 21 9 9.4 8 2.8 5.5 6 + 21 2.1 + 6 4 6 17 I I
PM80 Blood culture I 2.3 + 12 21 9 9.4 8 2.8 4 + 6 7 + 7.7 2.1 + 6 4 6 17 2.5 + 6.7 4 I I
PM82 Blood culture I 2.3 + 12 21 9 9.4 8 2.8 4 + 6 6 + 19 2.1 + 6 4 6 17 22 —— I III
PM118 Sputum I 2.3 + 12 21 9 9.4 8 2.8 4 + 6 6 + 19 2.1 + 6 4 6 17 I I
PM146 Lung postmortem I 2.3 + 12 21 9 9.4 8 2.8 4 + 6 4 2.1 + 6 4 6 17 I NT
SGH-3 PM12 Blood culture II 2.3 + 7.5 21 7 6.6 8 2.8 + 3.8 4 + 6 3.5 + 4 2.1 + 6 0.8 + 14 3.8 9.4 I II
PM149 Sputum II 2.3 + 7.5 21 7 6.6 8 2.8 + 3.8 4 + 6 3.5 + 4 2.1 + 6 0.8 + 14 3.8 9.4 I II
PM153 Throat Swab II 2.3 + 7.5 21 7 6.6 8 2.8 + 3.8 4 + 6 3.5 + 4 2.1 + 6 0.8 + 14 3.8 9.4 I II
PM154 Lung postmortem II 2.3 + 7.5 21 7 6.6 8 2.8 + 3.8 4 + 6 3.5 + 4 2.1 + 6 0.8 + 14 3.8 9.4 I II
PM19 Blood culture II 2.3 + 7.5 21 7 6.6 8 2.8 4 + 6 3.5 + 4 2.1 + 6 0.8 + 14 3.8 9.4 I II
PM131 Nose II 2.3 + 7.5 21 7 6.6 8 2.8 4 + 6 3.5 + 4 2.1 + 6 0.8 + 14 3.8 9.4 I II
PM148 Sputum II 2.3 + 7.5 21 7 6.6 8 2.8 4 + 6 3.5 + 4 2.1 + 6 0.8 + 14 3.8 9.4 I II
PM45 Blood culture I 2.3 + 7.5 21 7 9.4 8 3.8 4 7 + 7.7 2.1 + 6 9.4 0.8 + 14 3 17 2.5 + 6.7 I NT
PM46 Blood culture I 2.3 + 7.5 21 7 9.4 8 3.8 4 7 + 7.7 2.1 + 6 9.4 0.8 + 14 3 17 2.5 + 6.7 I NT
PM99 Sternal wound swab I 2.3 + 7.5 21 7 9.4 8 3.8 4   3 + 19  2.1 + 6 9.4 4 3.8 17 8.2 8.2 I V
PM126 Sputum I 2.3 + 7.5 21 7 9.4 8 3.8 4 19 2.1 + 6 4 3.6 17 8.2 8.2 I I
PM50 Blood culture I 2.3 + 7.5 21 7 9.4 8 3.8 + 5 4   7 + 7.7 2.1 + 6 9.4 0.8 + 14 3 17 2.5 + 6.7 I III
PM139 Hip tissue I 2.3 + 7.5 21 7 9.4 8 3.8 + 5 4 9 2.1 + 6 9.4 3 17 VIII III
PM26 Blood culture I 2.3 + 7.5 21 7 9.4 8 10 3.8 7.7 + 19  2.1 + 6 9.4 0.8 + 14 3.8 8.9 I II
PM48 Blood culture I 2.3 + 12 21 7 9.4 8 3.8 4 7.7 + 12  2.1 + 6 4 4.5 9.4 I III
PM63 Sputum I 2.3 + 12 21 7 9.4 8 10 4  12 + 19  2.1 + 6 9.4 4 3.8 8.9 I II
PM150 Cerebrospinal fluid II 2.3 + 12 21 7 9.4 8 3.8 4 + 7 7.7 2.1 + 6 4 3.8 9.4 3 4 8.2 8.2 I III
PM152 Cerebrospinal fluid II 2.3 + 7.5 21 7 9.4 6 3.8 3.5 6 2.1 + 6 9.4 0.8 + 14 3.8 9.4 22 3 IX III
PM49 Blood culture I 2.3 + 7.5 21 7 6.6 8 3.8 5.5 7.7 + 9   2.1 + 6 0.8 + 14 3.8 15 VI NT
PM16 Blood culture I 2.3 + 7.5 21 6.5 6.6 10 3.8 0.8 + 3.5 3.5 + 7.7 2.1 + 6 6 4 8.2 8.2 X III
PM10 Sputum I 2.3 + 12 21 6.5 6.6 10 3.8 3.5 3.5 + 7.7 2.1 + 6 6 4 8.2 8.2 III NT
PM1 Nose II 2.3 + 7.5 21 7 9.4 8 3.8 4 + 7   7 + 12 2.1 + 6 4 3.8 9.4 9.5 8.2 8.2 I I
PM24 Blood culture II 2.3 + 7.5 21 7 9.4 8 3.8 4 + 7 6 2.1 + 6 4 3.8 9.4 8.2 8.2 I I
a

The table summarizes the results of all experiments. The four reference strains are listed first, and then MSSA strains have been listed in cluster groups corresponding to those in Fig. 1. The following pairs of isolates were from the same patients: PM116 and PM122, PM52 and PM54, PM153 and PM154, and PM45 and PM46. 

b

Source of each clinical isolate. 

c

agr class was determined as described in Materials and Methods. 

d

RFLP values are expressed as the size of ClaI fragment hybridizing to each core gene (rnaIII, sarA, ssp, spa, icaA, fnbA, efb, hlb, hlg) or accessory gene (cna, cap5, cap8, lukE, splB, tst, sea, seb, sec, sed, sed, seg, seh, sei), by Southern blotting. Numbers refer to the size of the ClaI fragment hybridizing to each probe in Southern blot (kb). When two bands hybridized to the same probe, both are listed separated by a plus sign; this occurs when there are two copies of the gene or there is a ClaI restriction site within the gene. Clusters (see Fig. 1) are indicated in the first column. —, absence of that gene. 

e

Ribotypes were ascribed by us in this study. 

f

Phage groups were assigned as described in Materials and Methods. NT, nontypeable by phage typing.